Vorinostat Withdrawn Phase 1 / 2 Trials for Malignant Pleural Mesothelioma (MPM) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs